Dietary alpha-1,4-glucans

Dietary polysaccharides with alpha-1,4-glycosidic linkages, primarily starch (composed of amylose and amylopectin) and glycogen, are the major sources of glucose in the human diet (1). These complex carbohydrates undergo enzymatic hydrolysis initiated by salivary and pancreatic alpha-amylase, which targets the internal alpha-1,4-bonds, followed by further breakdown by brush-border enzymes like maltase and sucrase in the small intestine (2). The rate at which these linkages are cleaved directly influences the glycemic index of foods and the subsequent insulin response, making them central to the management of metabolic disorders. In clinical practice, these polysaccharides are not targets themselves but are the substrates for enzymes targeted by alpha-glucosidase inhibitors like acarbose to treat type 2 diabetes (3). By slowing the degradation of these alpha-1,4-linkages, these drugs effectively flatten the postprandial glucose curve and improve long-term glycemic control (4). Understanding the structural complexity and digestion kinetics of these polysaccharides is essential for developing nutritional and pharmacological strategies for obesity and metabolic syndrome (1, 2). (1) StatPearls, Biochemistry, Carbohydrates; (2) NCBI, Digestion and Absorption of Carbohydrates; (3) PubChem, Acarbose; (4) NIH, Dietary Carbohydrates and Glucose Control.

Other names

StarchAmyloseAmylopectinGlycogenAlpha-1,4-linked polysaccharidesDietary polysaccharides with alpha-1,4-glycosidic linkages

Competitive inhibition of alpha-amylase and membrane-bound intestinal alpha-glucosidase enzymes, which prevents the hydrolysis of alpha-1,4-glycosidic linkages in dietary polysaccharides, thereby delaying the absorption of glucose and reducing postprandial blood glucose levels (3).